Characterization and evaluation of β-glucan formulations as injectable implants for protein and peptide delivery

Author： Jacobs Simone   Bunt Craig R.   Wu Zimei   Lehr Claus-Michael   Rupenthal Ilva D.  

Publisher： Informa Healthcare

ISSN： 0363-9045

Source： Drug Development and Industrial Pharmacy, Vol.38, Iss.11, 2012-11, pp. : 1337-1343

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Physiochemical Characterization of β-glucan and in vitro Release of Lactoferrin from β-glucan Microparticles

By  

Current Drug Delivery, Vol. 10, Iss. 6, 2013-01 ,pp. : 713-721

Bentham Science Publishers

Access to resources Recommend Favorite

Characterization of Particulate Drug Delivery Systems for Oral Delivery of Peptide and Protein Drugs

By  

Current Pharmaceutical Design, Vol. 21, Iss. 19, 2015-06 ,pp. : 2611-2628

Bentham Science Publishers

Access to resources Recommend Favorite

Aerothricins: a new class of β-glucan inhibitors

By  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 2, 2002-02 ,pp. : 315-318

Informa Healthcare

Access to resources Recommend Favorite

New β-glucan inhibitors as antifungal drugs

By Hector Richard F   Bierer Donald E  

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 10, 2011-10 ,pp. : 1597-1610

Informa Healthcare

Access to resources Recommend Favorite

Texture and lubrication properties of functional cream cheese: Effect of β‐glucan and phytosterol

By  

JOURNAL OF TEXTURE STUDIES, Vol. 49, Iss. 1, 2018-02 ,pp. : 11-22

John Wiley & Sons Inc

Access to resources Recommend Favorite